AVANIR Pharmaceuticals Announces It Has Been Selected For Addition To The NASDAQ Biotechnology Index

SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ: AVNR) announced today that the Company has been selected for addition to the NASDAQ Biotechnology Index, which will be effective at the market’s opening on Monday, November 20, 2006.
MORE ON THIS TOPIC